NCT03628612Enrolling by invitationPhase 2
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Long-term Follow-up of Patients Previously Treated With Autologous T Cells Genetically Modified With Viral Vectors
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
Long-term follow-up of patients exposed to an AUTO CAR T cell therapy for up to 15 years following their first AUTO CAR T cell therapy infusion.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 7 Jul 2018
- Start date
- 2 Aug 2018
- Primary completion date
- Jul 2043
- Lead sponsor
- Autolus Limited
- Diseases
- Multiple myeloma, Childhood cancers
- NCT number
- NCT03628612
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 500
- From 2 Aug 2018 to the primary completion date, Jul 2043
- 9 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There are no specific exclusion criteria for this study.
Who the study is looking for
- Patients must have received an AUTO CAR T cell therapy on a clinical treatment study.
- Patients must have provided informed consent for long-term follow-up study prior to participation.
- Patients must be able to comply with the study requirements.
Age in the registry: 1 year to - · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
| Queen Elizabeth University Hospital Coordinator of this site? Confirm its status | Glasgow | United Kingdom | Unknown status |
| University College London Hospitals NHS Foundation Trust Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Manchester Royal Infirmary Hospital Coordinator of this site? Confirm its status | Manchester | United Kingdom | Unknown status |
| Royal Manchester Children's Hospital Coordinator of this site? Confirm its status | Manchester | United Kingdom | Unknown status |
| Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Coordinator of this site? Confirm its status | Newcastle upon Tyne | United Kingdom | Unknown status |
| St. David's South Austin Medical Center Coordinator of this site? Confirm its status | Austin | United States | Unknown status |
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
| Washington University in St. Louis Coordinator of this site? Confirm its status | St Louis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.